Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0MZ9A
|
||||
| Former ID |
DIB012363
|
||||
| Drug Name |
Suronacrine maleate
|
||||
| Synonyms |
HP-128; Suronacrine maleate < Rec INNM; Rac-9-(Benzylamino)-1,2,3,4-tetrahydroacridin-1-ol maleate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10:F01-F07, F04, F05, R41.3] | Phase 3 | [551848] | ||
| Formula |
C24H24N2O5
|
||||
| Canonical SMILES |
OC1CCCc2nc3ccccc3c(NCc4ccccc4)c12
|
||||
| InChI |
1S/C20H20N2O/c23-18-12-6-11-17-19(18)20(15-9-4-5-10-16(15)22-17)21-13-14-7-2-1-3-8-14/h1-5,7-10,18,23H,6,11-13H2,(H,21,22)
|
||||
| InChIKey |
HERUZAOANPGYSY-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 113108-86-4
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Modulator | ||
| Acetylcholinesterase | Target Info | Modulator | |||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||